Knockdown of MEF2D inhibits the development and progression of B-cell acute lymphoblastic leukemia.

Chang, Ning; Feng, Jianhua; Liao, Peiyun; Hu, Yuxing; Li, Meifang; He, Yanjie; Li, Yuhua

Chang, Ning; Feng, Jianhua; Liao, Peiyun; Hu, Yuxing; Li, Meifang; He, Yanjie; Li, Yuhua.

Afiliação

Chang N; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Feng J; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Liao P; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Hu Y; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Li M; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
He Y; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Li Y; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Transl Cancer Res ; 12(2): 287-300, 2023 Feb 28.

Article em En | MEDLINE | ID: mdl-36915581

Palavras-chave

B-cell acute lymphoblastic leukemia (B-ALL); myocyte enhancer factor 2D (MEF2D); phosphatidylinositol-4,5-bisphosphate 3-kinase-protein kinase B (PI3K-AKT); tumor progression

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Transl Cancer Res Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google